Dipyridamole is known to inhibit platelet aggregation and to induce vasodilatation. It has been shown that dipyridamole increases blood flow in various tissues in humans as well as in the eyes of animals. We studied the influence of dipyridamole in a prospective open trial in 23 patients with impair
Effect of dipyridamole on the blood flow in coronary aneurysms resulting from Kawasaki disease
β Scribed by Tomio Kobayashi; Katsuhiko Sone
- Publisher
- Springer
- Year
- 1994
- Tongue
- English
- Weight
- 542 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0172-0643
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Medical treatment of angina pectoris is largely based on the use of beta-blocking agents, calcium antagonists, and nitrates. Oxyfedrine, an amino ketone derivative and partial agonist at beta receptors, has been shown to have potent antianginal properties and to increase coronary blood flow in norma
Regional cerebral blood flow (rCBF) was studied in nine patients with Alzheimer's disease before and after trestment with tacrine. A small but significant improvement in cognitive functioning on the drug was not accompanied by significant changes in rCBF for the group as a whole. However, when the a